How many investments has HighCape Capital made?

HighCape Capital has 14 tracked investments, 2 of which have exited.

What stage does HighCape Capital invest at?

HighCape Capital invests at the Series C, Growth, Late Stage stages.

What sectors does HighCape Capital focus on?

HighCape Capital focuses on Biotech, Digital Health, Healthtech, Medical Devices.

Where is HighCape Capital located?

HighCape Capital is headquartered in Westport, US.

Who does HighCape Capital co-invest with?

HighCape Capital most often shares deals with Connecticut Innovations, Ascension Ventures, Canaan Partners, among 11 tracked co-investors.

HighCape Capital

Growth equityoperating company · company profile

Westport · Series C–Late Stage · 7 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into HighCape Capital

1,026 people in our graph share verified history with the HighCape Capital team — schools, employers, funds. One of them is your warm intro.

Elias Quijanounlockedknows Ranjit Bindra · together at Modifi Bio (overlapped)

knows the team · via Clinical Data Inc.

×2knows the team · via Wellinks

knows the team · via Syngenta

×2knows the team · via Viacom

×4knows the team · via MSKCC

✨ Fox Verdict

Investment thesis

HighCape Capital is a growth equity fund focused exclusively on the life sciences sector, investing across connected health, medical devices and tools, and biotechnology. Founded in 2013 by industry veterans with backgrounds in founding, financing, leading, growing and exiting life sciences companies, the firm applies deep operating and investment experience to support portfolio companies. Its value-add approach centers on leveraging its multidisciplinary team's expertise, working collaboratively and hands-on with management teams to strengthen commercial and operational execution, and supporting entrepreneurship. The team members each bring at least 25 years of experience across the global life sciences industry, aiming to build world-class companies while creating value for limited partners and the broader healthcare system.

Invests inBiotech Digital Health Healthtech Medical Devices United States Westport

Source: firm website, verified Sep 27, 2026.

Stage

Series C–Late Stage

Westport, Maryland, US

Instruments

Equity

Founded

2013

Private fund assets

$48M

VC funds

Tracked investments

IPOs

Team · 7 people

from the firm's website & public directories

Kevin Rakin· Partner· New York City Metropolitan Areain

Kevin Rakin is co-founder of HighCape Capital with more than 30 years of experience as a life sciences investor and executive. He previously led Shire Regenerative Medicine and Advanced BioHealing, and co-founded Genaissance Pharmaceuticals. He holds an MBA from Columbia University.

Matt Zuga· Partner· New York, New York, United Statesin

Matt Zuga is co-founder of HighCape Partners with more than 20 years of life sciences investment and banking experience. He was formerly a Managing Director at Syngenta Ventures and co-founded Red Abbey Venture Partners. He holds an MBA from UNC Chapel Hill.

Carol Reed· Operating Partner· Asheville, North Carolina, United Statesin

Dr. Carol Reed has over 20 years of drug and device development experience and 10 years as a practicing physician in pulmonary and critical care medicine. She was previously Chief Medical Officer at Clinical Data, Inc. She holds an MD from Rush Medical College.

Charles Hart· Operating Partner· Franklin, Tennessee, United Statesin

Dr. Charles Hart brings over 35 years of R&D experience in biotechnology. He previously held VP of Research and Chief Scientific Officer roles at Shire Regenerative Medicine, Advanced BioHealing and BioMimetic Therapeutics, and spent 21 years at ZymoGenetics. He holds a Ph.D. from the University of Washington.

Dean Tozer· Partner· Nashville, Tennessee, United Statesin

Dean Tozer has more than 30 years of experience in the global healthcare industry commercializing life sciences products. He previously served as CEO of Nuo Therapeutics and VP of Corporate Development at Shire Regenerative Medicine. He holds a Bachelor of Commerce from Saint Mary's University.

Jennifer Barretta· Partner· United Statesin

Jennifer Barretta brings 25 years of human resources experience, advising HighCape portfolio companies on HR management and leadership development. She previously served as VP of Human Resources at Shire Regenerative Medicine and Advanced BioHealing, and holds a B.S. in Business Management from Syracuse University.

Ranjit Bindra· Operating Partner· New Haven, Connecticut, United Statesin

Dr. Ranjit Bindra is a physician-scientist and professor at Yale School of Medicine and Scientific Director of the Yale Brain Tumor Center. A biotech entrepreneur, he founded six companies including HighCape-funded Cybrexa, Alphina and Modifi Biosciences (acquired by Merck in 2024).

Founder mafia

5 people who came through HighCape Capital went on to found or lead other companies.

Ranjit BindraOperating PartnerFounded Modifi Biosciences +2 Matt ZugaPartnerFounded HighCape Capital Jennifer BarrettaPartnerFounded Wellinks Kevin RakinPartnerFounded HighCape Capital Dean TozerPartnerFounded Nuo Therapeutics

What they invest in

from 11 of 14 portfolio companies

Biotech ×7Healthtech ×6Medical Devices ×3Deep Tech ×1Digital Health ×1Fintech ×1Hardware ×1Logistics & Supply Chain ×1

HQs:United States×9

Investments · 14 tracked

founders shown can be your intro path

By year:2024 · 1 2023 · 1 2018 · 13 dated

Aziyo BiologicsNASDAQ: ELUT

Aziyo Biologics (operating as Elutia) develops drug-eluting biomatrix products that combine biologic scaffolds with localized antibiotic delivery to reduce surgical complications in reconstructive and soft tissue repair procedures.

BiotechSilver Spring, US

Michelle LeRoux Williams(Executive Officer)Jeffrey D Hamet(Executive Officer)Lode Debrabandere(Executive Officer, Director)C. Randal Mills(President, Chief Executive Officer, Director)

BoardWilliam Matthew Zuga(Director)Kevin Rakin(Director)in

TELA Biotelabio.com in 𝕏NASDAQ: TELA

Offers soft tissue repair solutions combining naturally sourced tissue with polymer; lead product OviTex for hernia repair (NASDAQ: TELA), based in Malvern, PA.

BiotechMalvern, US

Antony Koblish(Founder)inFrancis Conway(Executive Officer)Maarten Persenaire(Executive Officer)Christine Arasin(Executive Officer)

Board Kevin Rakin(Director)inAshley Freidman(Director)

Co-investorsCheckmate Capital Group LLC Essex Woodlands Healthcare Partners OrbiMed Signet Healthcare Partners 1315 Capital RTW Investments L.P.

Alphina Therapeuticsalphinatx.com in

Develops therapeutics targeting altered NAD metabolism in cancer, using IP licensed from Yale University.

BiotechNew Haven, US

Barbara Fox(Executive Officer, Director)Nicholas J Galli(Executive Officer, Director)Stanley Choy(Executive Officer)in Ranjit Bindra(Director)in

Board Colleen Cuffaro(Director)inMatthew Cohen(Director)in

Co-investorsCanaan Partners Connecticut Innovations OUP (Osage University Partners)

Cheetah Medicalcheetah-medical.com in

Leader in non-invasive cardiac output and hemodynamic monitoring with its CHEETAH NICOM system; based in Newton, MA with offices in Tel-Aviv and Portland.

HealthtechNewton, US

Christopher Hutchison(Executive Officer, Director)inKevin McArdle(Executive Officer)Yuval Rozen(Executive Officer)

BoardSteven Reeders(Director)Renard Charity(Director)inAnthony Moshal(Director)

Co-investorsAscension Ventures Robert Bosch Venture Capital MVM Life Science Partners

Cybrexa, Inc.cybrexa.com in 𝕏

Cybrexa is a biotechnology company developing cancer therapeutics that use its alphalex peptide-drug conjugate platform to target the low-pH tumor microenvironment for selective delivery.

BiotechHealthtechMedical DevicesNew Haven, US

Per Hellsund(Co-founder, President & CEO)in Ranjit Bindra(Scientific Co-founder & Chief Scientific Advisor)inPeter Glazer(Scientific Co-founder & Chief Medical Advisor)inF. Kevin Didden(Manager)

BoardKevin Rakin(Manager)

Co-investorsConnecticut Innovations

Elutiaelutia.com in 𝕏

Elutia develops a proprietary drug-eluting biomaterial platform that combines biologic matrices with extended antibiotic release for use in device implantation and soft tissue reconstruction.

BiotechHealthtechMedical Devices

C. Randal Mills(Founder, President & CEO)in

Modifimodifi.com in 𝕏Oct 2023 · $4.3M

MODIFI provides a digital platform for cross-border trade finance, letting exporters and importers onboard online, receive payment right after shipping, and track trades and supplier payouts in one dashboard.

FintechLogistics & Supply ChainSaaSBainbridge Island, US

Jan Wehrs(Founder)in Sven Brauer(Founder)in Nelson Holzner(Co-Founder & CEO)inJames Poss(Executive Officer, Director, Promoter)Matthew Otepka(Executive Officer)J. Todd Larson(Executive Officer)

Co-investorsIncubate Fund Maersk Growth Neva Sgr.PICUS CAPITAL Global Founders Capital Pathway Bioventures

Modifi Biosciencesmodifibio.com in 𝕏Aug 2024 · $4.3M

Modifi Bio presents itself as a research-focused biopharmaceutical company developing medicines and vaccines.

BiotechHealthtechNew Haven, US

Ranjit Bindra(Director)inKingson Lin(Cofounder)in Kevin L. Rakin(Executive Officer, Director)in

BoardLucas de Breed(Director)Kat Kayser-Bricker(Director)

Co-investorsConnecticut Innovations Pathway Bioventures BrightEdge Ironwood Capital

Quantum Siquantum-si.com in 𝕏

Quantum-Si develops next-generation protein sequencing technology that enables single amino acid detection by combining biology, chemistry, artificial intelligence, and semiconductor technology.

BiotechDeep TechHardwareMedical Devices

Jeff Hawkins(CEO)inJeff Keyes(Chief Financial Officer)inChristian LaPointe(General Counsel)inTodd Rearick(Chief Technology Officer)inLindsay Thompson(Chief Human Resources Officer)in

Co-investorsForesite Capital YuanBio Venture Capital

Wellinkswellinks.com in 𝕏Jul 2018

Wellinks provides virtual pulmonary care for patients with respiratory conditions such as COPD, offering at-home remote monitoring, virtual pulmonary rehabilitation, one-on-one clinical coaching, and nurse triage.

Digital HealthHealthtechWellness & FitnessNew Haven, US

Ellen Su(Executive Officer, Director)inLevi DeLuke(Executive Officer, Director)in

Co-investorsConnecticut Innovations

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

AlphinaConvexity ScientificCybrexa TherapeuticsZipLine Medical

Exits · 2

2 IPOs

Aziyo BiologicsNASDAQ: ELUTTELA BioNASDAQ: TELA

Portfolio news

latest coverage across their companies

Wellinks Secures $25M to Expand Virtual COPD Management | News | Wellinks

Wellinks · wellinks.com · Aug 18, 2025

Frequently asked questions

How many investments has HighCape Capital made?: HighCape Capital has 14 tracked investments, 2 of which have exited.
What stage does HighCape Capital invest at?: HighCape Capital invests at the Series C, Growth, Late Stage stages.
What sectors does HighCape Capital focus on?: HighCape Capital focuses on Biotech, Digital Health, Healthtech, Medical Devices.
Where is HighCape Capital located?: HighCape Capital is headquartered in Westport, US.
Who does HighCape Capital co-invest with?: HighCape Capital most often shares deals with Connecticut Innovations, Ascension Ventures, Canaan Partners, among 11 tracked co-investors.

Similar investors

Amadeus Capital Partners

Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.

$50K – $12.7M

B Capital Group

B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.

$10M – $50M

Capricorn Venture Partners

Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.

$270K – $10.8M

DCVC (Data Collective)

DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.